Centessa Pharmaceuticals
The Senior Advisor, Manufacturing Package Design leads the design, development, and technical strategy for primary and secondary packaging supporting late-stage clinical and commercial-stage drug product manufacturing. This role provides technical and strategic leadership for packaging systems, ensuring solutions meet quality, regulatory, and commercial manufacturing readiness requirements. The position involves cross-functional collaboration with Manufacturing, Quality, Regulatory Affairs, and Supply Chain, as well as external Contract Manufacturing/Packaging Organizations (CMOs/CPOs).
Centessa Pharmaceuticals is a global biopharmaceutical company that uses an asset‑centric, portfolio model to accelerate the development of innovative medicines. With a patient‑centric mission, Centessa advances programs across sleep‑wake, neurological, neurodegenerative and psychiatric disorders — notably pursuing an Orexin Receptor 2 agonist program. The company combines specialized operating subsidiaries and centralized capabilities to move preclinical and clinical‑stage assets efficiently toward regulatory approval and commercialization. Centessa partners with academic and industry collaborators to translate promising science into transformative treatment options for patients.
Why Centessa Pharmaceuticals (CNTA) Is Up 5.7% After Advancing ORX750 Toward Registrational Sleep-Disorder Trials
1 day ago
FMR LLC's Strategic Acquisition of Centessa Pharmaceuticals Shar
1 month ago
Centessa Pharmaceuticals plc Announces Underwritten Public Offering of American Depositary Shares
Nov 11, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Centessa Pharmaceuticals.
Centessa (NASDAQ: CNTA) commences underwritten ADS offering; 30-day option up to 15%
Nov 11, 2025
Associate Director, Drug Substance (Process Chemistry)
Pulmovant
Sr. Commercial Manufacturing API Manager
Neurocrine Biosciences
Associate Director, Technical Operations, Biologics Drug Substance Manufacturing
Travere Therapeutics
Associate Scientific Director, Manufacturing Science & Technology (MSAT)
Neurocrine Biosciences
Packaging Engineer I
Gilead Sciences
Commercial Manufacturing Operations Manager
Neurocrine Biosciences